magazine 29 May 2025
Download PDF Page flip version
Eli Lilly versus Novo-Nordisk in the weight loss war and the mini-Berkshire chalking up stellar returns.
Company doesn’t see record levels from this area being repeated in the current financial year
Long-term bond yields have risen despite weakening economic data
Steps you can take to prepare properly for your financial future
Specialty chemicals group has been under pressure from its biggest shareholder to unlock value
Second-quarter earnings on 5 June are important for millions of investors
Your provider has a duty to keep you regularly informed in the run-up to retirement
Tariff uncertainty and US exposure knocks company’s confidence
A whistle-stop tour of new faces, farewells, winners and losers
US currency weakness has been a supportive factor for developing world stocks in the first part of 2025
Three things the Templeton Emerging Markets Investment Trust team are thinking about right now
These two companies have become the largest drug makers by market cap in the US and Europe
‘We believe having uniquely aligned and stable capital partners is a competitive advantage’ Markel CEO Thomas Gaynor
Understanding the reasons behind NAV discounts and why you need to put them in context before making an investment decision
It could take a long time to reverse decades of lagging behind the US
Shareholders will hope it’s ‘steady as she goes’ in terms of the full-year outlook
The business has consistently outperformed its markets over the long term
Renamed and under new management, this trust offers exposure to attractively-valued market leaders with pricing power
Shares in Latin American ecommerce and digital finance firm have soared although long-term investors may want to stick rather than twist
The potential for double-digit profit growth and increasing cash generation is not reflected in a lowly eight times forward PE
Watching events in Tokyo closely is likely to be a smart move
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
